ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Gyno-Terazol®:Janssen-Cilag AG
Information professionnelle complèteDDDimprimé 
Forme gal./Grpe.th.Composit.PropriétésPharm.cinét.Indic./emploiPosolog./mode d'empl.PrécautionsEffets indésir.
Interact.SurdosageRemarquesNum. SwissmedicMise à jour 
G01AG02 - TerconazoleATC-DDD Version 2016. Source: WHO
G - Genito Urinary System and Sex Hormones
 
G01 - Gynecological Antiinfectives and Antiseptics

This group comprises gynecological antiinfectives and antiseptics mainly for local use. See also:
J - Antiinfectives for systemic use
D06 - Antibiotics and chemotherapeutics for dermatological use
P01AB - Nitroimidazole derivatives

The DDDs are based on the treatment of vaginal infections.

G01A - Antiinfectives and Antiseptics, Excl. Combinations with Corticosteroids

This group comprises preparations, mainly for local use.
Combinations with corticosteroids, see G01B.
Antivirals for topical use, including gynecological use, such as podophyllotoxin, are classified in D06 - Antibiotics and chemotherapeutics for dermatological use.

G01AG - Triazole Derivatives

Fluconazole tablets in single dose packages, only for gynecological infections, are classified together with other packages for systemic use in J02A - Antimycotics for systemic use.

G01AG02 - Terconazole
Concentr.Adm.RouteNote
 V 
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home